What does this research mean for the field?

Methylene blue is a highly suitable candidate for repurposing into activatable prodrugs for precise disease theranostics due to its established clinical safety profile and intrinsic optical properties. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To explore the use of methylene blue as an activatable prodrug in theranostics for enhanced disease diagnosis and treatment.

April 18, 2026Chemical Communications0 citations

Repurposing Methylene Blue as Activatable Prodrugs for Precise Disease Theranostics

JZJunliang Zhou LSLiang Su TRTian‐Bing Ren

Key Points

To explore the use of methylene blue as an activatable prodrug in theranostics for enhanced disease diagnosis and treatment.
Reviewed recent literature on methylene blue and its activatable prodrug forms.
Analyzed safety profiles and optical properties of methylene blue.
Discussed applications in disease theranostics.
Methylene blue shows promising potential as an activatable prodrug for precise disease targeting.
Its optical properties enhance imaging capabilities for diagnostics.
The established safety profile supports its ongoing clinical use and development.

Abstract

This review systematically summarizes recent advances in activatable prodrugs based on methylene blue (MB) for disease theranostics. Owing to its long-standing clinical use, well-characterized safety profile, and intrinsic optical properties,...

KI fragen

Bookmark

View Full Paper

Cite This Study

Zhou et al. (Thu,) studied this question.

synapsesocial.com/papers/69e3213840886becb6540593 https://doi.org/https://doi.org/10.1039/d6cc01225f

KI fragen

Bookmark

View Full Paper